Английская Википедия:Estradiol benzoate/estradiol phenylpropionate

Материал из Онлайн справочника
Версия от 19:24, 4 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|Combination drug}} {{Drugbox | image = Estradiol benzoate.svg | width = 250px | caption = | image2 = Estradiol phenylpropionate structure.svg | width2 = 250px | caption2 = Estradiol benzoate (top) and<br />estradiol phenylpropionate (bottom) <!--Combo data--> | type = combo | drug_name = Estradiol benzoate / <br />estradiol phenylpropionate | component1 =...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

Estradiol benzoate/estradiol phenylpropionate (EB/EPP), sold under the brand name Dimenformon Prolongatum, is an injectable combination formulation of estradiol benzoate (EB), a shorter-acting estrogen, and estradiol phenylpropionate (EPP), a longer-acting estrogen, which has been used in menopausal hormone therapy for women in Europe but appears to no longer be available.[1][2][3][4] It has also been used to suppress lactation in women and has been used in feminizing hormone therapy for transgender women.[5][6] It has been provided in the form of 1 mL ampoules containing 2.5 mg EB and 10 mg EPP in oil solution and is administered by intramuscular injection at regular intervals.[2]

The pharmacokinetics of this formulation and its constituent components have been studied.[7][8][9][10][11][12]

A combination of 12.5 mg EB and 10 mg EPP (developmental code name Org 369–2) has been studied for use in women as a postcoital contraceptive within 48 hours of unprotected sex.[13][9][14][15][16]

See also

References

Шаблон:Reflist

Шаблон:Estrogens and antiestrogens Шаблон:Estrogen receptor modulators Шаблон:Genito-urinary-drug-stub